NeoNeuro

NeoNeuro
Area Bio Tech
Creation date June 1st, 2015
Development stage Proof of concept

Presentation

NeoNeuro is being established in France as a subsidiary of NeoVentures Biotechnology Inc. (a Canadian company) to manage the development and commercialization of NeoVentures Biotechnology Inc. aptamer discovery platform for neurological and psychiatric disorders. This new company has a non-royalty bearing license to the application of NeoVentures intellectual property for the discovery and commercialization of aptamer based ligands directly against tissues and bodily fluids.The immediate focus of NeoNeuro will be the identification of aptamers for Alzheimer's disease biomarkers in brain tissue and in blood serum, and the subsequent commercial development of such ligands for diagnostic and/or therapeutic applications.

See also